Home
>
National Drug Code (NDC)
>
Fluoroplex
Fluoroplex - 16110-812-30 - (fluorouracil)
Drug Information of Fluoroplex
| Product NDC: | 16110-812 |
| Proprietary Name: | Fluoroplex |
| Non Proprietary Name: | fluorouracil |
| Active Ingredient(s): | 10 mg/g & nbsp; fluorouracil |
| Administration Route(s): | TOPICAL |
| Dosage Form(s): | CREAM |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Fluoroplex
| Product NDC: | 16110-812 |
| Labeler Name: | Aqua Pharmaceuticals, LLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA016988 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19931203 |
Package Information of Fluoroplex
| Package NDC: | 16110-812-30 |
| Package Description: | 1 TUBE in 1 CARTON (16110-812-30) > 30 g in 1 TUBE |
NDC Information of Fluoroplex
| NDC Code | 16110-812-30 |
| Proprietary Name | Fluoroplex |
| Package Description | 1 TUBE in 1 CARTON (16110-812-30) > 30 g in 1 TUBE |
| Product NDC | 16110-812 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | fluorouracil |
| Dosage Form Name | CREAM |
| Route Name | TOPICAL |
| Start Marketing Date | 19931203 |
| Marketing Category Name | NDA |
| Labeler Name | Aqua Pharmaceuticals, LLC |
| Substance Name | FLUOROURACIL |
| Strength Number | 10 |
| Strength Unit | mg/g |
| Pharmaceutical Classes | Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC] |
